We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+12.32%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$210M
AUM Growth
+$31.7M
Cap. Flow
+$22.1M
Cap. Flow %
10.52%
Top 10 Hldgs %
41.52%
Holding
75
New
29
Increased
9
Reduced
14
Closed
17

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$5.11M
2
AVNS icon
Avanos Medical
AVNS
+$3.8M
3
RVTY icon
Revvity
RVTY
+$3.35M
4
ELGX
Endologix Inc
ELGX
+$2.9M
5
NVRO
NEVRO CORP.
NVRO
+$2.66M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$7.56M
2
GSK icon
GSK
GSK
+$6.33M
3
CAH icon
Cardinal Health
CAH
+$4.73M
4
PBYI icon
Puma Biotechnology
PBYI
+$4.48M
5
SNY icon
Sanofi
SNY
+$4.24M

Sector Composition

Rank Sector Weight
1 Healthcare 50.87%
2 Financials 3.75%
3 Industrials 2.24%
4 Technology 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIOX
51
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$689K 0.33%
+3,713
New +$651K
FOMX
52
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$646K 0.31%
+139,200
New +$621K
DMK
53
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$637K 0.3%
1,750
-10,862
-86% -$3.25M
SYRE icon
54
Spyre Therapeutics
SYRE
$8.67B
$499K 0.24%
5,183
-1,613
-24% -$223K
PFNX
55
DELISTED
Pfenex Inc.
PFNX
$344K 0.16%
85,867
– –
PHG icon
56
CALL
Philips
PHG
$26B
$319K 0.15%
+11,725
New +$307K
OASM
57
DELISTED
Oasmia Pharmaceutical AB
OASM
$214K 0.1%
203,170
+5,700
+3% +$10K
VIRX
58
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$91K 0.04%
963
-7,949
-89% -$913K
ALNY icon
59
PUT
Alnylam Pharmaceuticals
ALNY
$37.7B
– –
-13,500
Closed -$692K
BIIB icon
60
Biogen
BIIB
$29.8B
– –
-27,650
Closed -$7.56M
BSX icon
61
Boston Scientific
BSX
$68.4B
– –
-90,000
Closed -$2.24M
CAH icon
62
Cardinal Health
CAH
$53.7B
– –
-57,950
Closed -$4.73M
CHRS icon
63
Coherus Oncology
CHRS
$225M
– –
-63,800
Closed -$1.35M
IQV icon
64
PUT
IQVIA
IQV
$35.3B
– –
-21,500
Closed -$1.73M
MOH icon
65
CALL
Molina Healthcare
MOH
$10.7B
– –
-50,000
Closed -$2.28M
MRK icon
66
PUT
Merck
MRK
$325B
– –
-83,840
Closed -$5.08M
PFE icon
67
PUT
Pfizer
PFE
$141B
– –
-105,400
Closed -$3.42M
RCKT icon
68
Rocket Pharmaceuticals
RCKT
$360M
– –
-181,725
Closed -$1.45M
TEVA icon
69
Teva Pharmaceuticals
TEVA
$36.2B
– –
-69,500
Closed -$2.23M
VRTX icon
70
Vertex Pharmaceuticals
VRTX
$122B
– –
-19,475
Closed -$2.13M
LUMO
71
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-2,824
Closed -$613K
TMBR
72
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
– –
-21
Closed -$158K
CERN
73
PUT
DELISTED
Cerner Corp
CERN
– –
-20,000
Closed -$1.18M
FWP
74
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
– –
-2,032
Closed -$306K
ANTH
75
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
– –
-41,714
Closed -$142K
1 2
3

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return

Sio Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Sio Capital Management held 75 positions worth $210M, up 18% from $179M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sio Capital Management deployed $22.1M of net new capital in Q2 2017, opening 29 new positions and adding to 9 existing holdings. Its largest new stake was HCA Healthcare: 60,420 shares worth $5.27M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 64% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was GSK, an estimated $6.33M trimmed.

  • Sio Capital Management's largest Q2 2017 buy was HCA Healthcare: 60,420 shares worth $5.27M.
  • Sio Capital Management added most to Aetna Inc in Q2 2017, an estimated $2.11M increase.
  • Sio Capital Management's biggest Q2 2017 reduction was GSK, cutting an estimated $6.33M.
  • Sio Capital Management fully exited Biogen in Q2 2017, selling an estimated $7.56M.
  • Sio Capital Management's ten largest holdings make up 42% of its $210M portfolio in Q2 2017.
  • Sio Capital Management opened 29 new positions and closed 17 in Q2 2017.
  • Sio Capital Management's portfolio value rose 18% quarter-over-quarter to $210M.

Based on Sio Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.